vimarsana.com
Home
Live Updates
Mantle Cell Lymphoma - Breaking News
Pages:
7
8
9
10
11
12
13
Latest Breaking News On - Mantle cell lymphoma - Page 6 : vimarsana.com
Cord Blood-Derived Treatment Shows Promise in Blood Cancer
A CAR NK therapy made from cord blood showed promising responses in patients with relapsed or refractory B-cell malignancies.
United states
Katy rezvani
American cancer society
University of texas md anderson cancer center
American cancer
Has promising responses
Side effect
Cancer center
Mantle cell lymphoma
BTK Inhibitor–Associated AEs Can Influence Treatment Selection in MCL
William Pearse, MD, discusses the roles of acalabrutinib and zanubrutinib in mantle cell lymphoma, as well as the adverse effect profiles of each agent.
San diego
United states
Williamb pearse
University of california
San diego school of medicine
San diego school
William pearse
Mantle cell lymphoma
San diego school of medicine
Choosing CAR T-cells as Third-line and Beyond Therapy for FL
Jennifer Crombie, MD, discusses how to choose CAR T-cells as third-line and beyond therapy for FL.
Jennifer crombie
Recent updates
Follicular lymphoma
Mantle cell lymphoma
Beyond therapy
Cart cell therapy
Head to trial
Axi cel
Tisa cel
Grade 3 crs
Liso cel
Transcend fl
Transcend fl trial
Sequencing Immunotherapy in the Third-line and Beyond Setting for FL
Peter Martin, MD, discusses how to sequence bispecific T-cell engagers and CAR T-cell therapies in the third-line and beyond setting for FL.
Peter martin
Recent updates
Follicular lymphoma
Mantle cell lymphoma
Beyond setting
Patient preference
Cellular therapy
Clinical factor
Real world data
Quality of life
Bispecific antibody
Cart cell
Sequencing therapy
Cart cell therapy
Patient Factors, Safety, and Long-Term Efficacy Best Inform Treatment Selection Across Hematologic Malignancies
Michael Choi, MD, expands on significant advancements and treatment considerations in hematologic malignancies.
Michael choi
Benjamin heyman
Amanda kagan
Williamb pearse
University of california san diego
Onclive state
Science summit
California san diego
Advancements and treatment considerations in hematologic malignancies
Treatment options in chronic lymphocytic leukemia
Fda approval of momelotinib
Myelofibrosis with anemia
Rontline treatment with btk inhibitors
Mantle cell lymphoma
Cart cell therapy
Paul cheng
vimarsana © 2020. All Rights Reserved.